Artificial Intelligence Based Rapid Identification of ST-elevation Myocardial Infarction Using Electrocardiogram (ARISE)

Not Applicable

Completed

• Conditions: Myocardial Infarction, Acute
• Interventions: Other: AI-enabled ECG-based Screening Tool

• Registration Number: NCT05118009
• Lead Sponsor: National Defense Medical Center, Taiwan

Brief Summary

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based supporting tool for improving the diagnosis and management of ST-elevation myocardial infarction.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-11-01
• Study First Submitted QC: 2021-11-01
• Study First Posted: 2021-11-11
• Study Start: 2022-05-01
• Primary Completion: 2023-04-30
• Study Completion: 2023-05-31
• Status Verified: 2023-06
• Last Update Submitted: 2023-06-20
• Last Update Posted: 2023-06-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 43176

Inclusion Criteria

• Patients in emergency department or inpatient department.
• Patients recieved at least 1 ECG examination.

Exclusion Criteria

• The patients recieved ECG at the period of inactive AI-ECG system.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention	AI-enabled ECG-based Screening Tool	Patients randomized to intervention will have access to the screening tool.

Primary Outcome Measures

Name	Time	Method
E2C (ECG to coronary angiography) time	Within 6 hours	Time from ECG to activation of coronary angiography for STEMI patients.

Secondary Outcome Measures

Name	Time	Method
Highest concentration of high-sensitivity cardiac troponin I	Within 3 days	After performing an electrocardiogram, the highest concentration of high-sensitivity cardiac troponin I was followed.
D2C (Door to coronary angiography) time	Within 6 hours	Time from first medical contact to activation of coronary angiography for STEMI patients in emergency department.
Ejection fractrion	Within 3 days	Ejection fractrion primary percutaneous coronary intervention for STEMI patients.
Highest concentration of creatine kinase	Within 3 days	After performing an electrocardiogram, the highest concentration of creatine kinase was followed.
Length of hospitalization	Within 28 days	After performing an electrocardiogram, the length of hospitalization.
Number of CAG event	Within 6 hours	Number of CAG event
D2B (Door to Balloon Time) time	Within 6 hours	Time from first medical contact to complete of primary percutaneous coronary intervention for STEMI patients in emergency department.
E2B (ECG to primary percutaneous coronary intervention) time	Within 6 hours	Time from ECG to complete of primary percutaneous coronary intervention for STEMI patients.

Trial Locations

Locations (1)

National Defense Medical Center; 🇨🇳 Taipei, Taiwan